Document is current

Article History

Received: 6 February 2024

Accepted: 21 July 2024

First Online: 11 September 2024

Declarations

:

: M Betton, M Hureaux and A Blanchard declare no conflict of interest. P Houillier reports funding, consultancy and honoraria with Takeda Shire and consultancy with Kyowa-Kirin, outside of this study. R. Vargas-Poussou reports consultancy with Advicenne, outside of this study.

: The authors confirm that the study conforms to recognized standards of European Medicines Agency Guidelines for Good Clinical Practice and has been performed in accordance with the local ethical approvals committee of Assistance Publique—Hôpitaux de Paris and conducted in accordance with the 1964 Declaration of Helsinki and its later amendments.

: The procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 and 2008.

: Written consent for genetics analysis, publication of clinical information was obtained from all patients and legal representants, in accordance with French Bioethics Law of 2004.